When should ACE inhibitors be given to normotensive patients with IDDM

被引：18

作者：

Wang, PH

机构：

来源：

LANCET | 1997年 / 349卷 / 9068期

关键词：

D O I：

10.1016/S0140-6736(97)22025-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1782 / 1783

页数：2

共 5 条

[1]

*DIAB CONTR COMPL, 1993, NEW ENGL J MED, V329, P977, DOI DOI 10.1056/NEJM199309303291401

[2] PREVENTION OF DIABETIC RENAL-DISEASE WITH SPECIAL REFERENCE TO MICROALBUMINURIA [J].

MOGENSEN, CE ;

KEANE, WF ;

BENNETT, PH ;

JERUMS, G ;

PARVING, HH ;

PASSA, P ;

STEFFES, MW ;

STRIKER, GE ;

VIBERTI, GC .

LANCET, 1995, 346 (8982) :1080-1084

[3] The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: A meta-analysis [J].

Pedrini, MT ;

Levey, AS ;

Lau, J ;

Chalmers, TC ;

Wang, PH .

ANNALS OF INTERNAL MEDICINE, 1996, 124 (07) :627-+

[4] FAMILIAL CLUSTERING OF DIABETIC KIDNEY-DISEASE - EVIDENCE FOR GENETIC SUSCEPTIBILITY TO DIABETIC NEPHROPATHY [J].

SEAQUIST, ER ;

GOETZ, FC ;

RICH, S ;

BARBOSA, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (18) :1161-1165

[5] METAANALYSIS OF EFFECTS OF INTENSIVE BLOOD-GLUCOSE CONTROL ON LATE COMPLICATIONS OF TYPE-I DIABETES [J].

WANG, PH ;

LAU, J ;

CHALMERS, TC .

LANCET, 1993, 341 (8856) :1306-1309

← 1 →